Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab,...
Read moreEli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab,...
Read more
